top of page

Democrats At It Again, Fighting for Power, Not Consumers, With The Impeachment Threats.

1 hour ago
7 min read

By Scott Shields - Contributing Writer Capitol Times Media - Scott is also the

Co-Founder of a Consumer Protection Cryptography Company established in

2018


Ralph Nader built the consumer protection movement from outside the system — a lone

lawyer with a suitcase full of documents, pressing both parties to defend ordinary people

against concentrated corporate power. No one would have predicted that the tradition's

most consequential twenty-first-century chapter would be written by a billionaire real

estate developer turned Republican president. But look at the record, and above all at the

personnel: Donald Trump's decision to hand the Department of Health and Human

Services to Robert F. Kennedy Jr., a man who learned public-interest advocacy at Ralph

Nader's elbow, may be the clearest return of Nader-style consumerism to actual governing

power in half a century. And the response from the opposition has been telling: not a

competing consumer agenda, but a campaign to remove the advocate himself.


The Kennedy Connection


To understand why the Kennedy appointment matters, you have to understand its lineage.

Robert F. Kennedy Jr. spent decades as exactly the kind of lawyer Nader pioneered: an

environmental litigator who sued polluters directly. At Riverkeeper and the Pace

Environmental Litigation Clinic, he won landmark settlements forcing the cleanup of the

Hudson River and pioneered the use of citizen suits to hold corporate polluters

accountable. He spent years battling the chemical, agricultural, and pharmaceutical

industries he believed were harming the public, often against fierce resistance from his

own political tribe.


And his inspiration, by his own account, was Ralph Nader. Kennedy called Nader his "friend

and hero" and, as those who knew his career described it, a mentor. The two men shared a

conviction that both major parties had grown deaf to questions of corporate accountability

— and that somebody had to force the issue.


Their sharpest disagreement was instructive. In a New York Times op-ed on August 10,

2000, Kennedy pleaded with Nader to abandon his third-party run: "a vote for Mr. Nader is a

vote for Mr. Bush." Nader, principled to a fault, refused — and Kennedy warned publicly,

right up to Election Day, that Nader's candidacy "could draw enough votes in certain key

states from Al Gore to give the entire election to George W. Bush." He watched the

consequences with frustration for a generation.In 2024, history handed him the mirror-image of that choice. Mounting his own outsider

campaign on the same anti-corporate-consolidation themes Nader had raised, Kennedy

initially refused to bow out, "Americans shouldn't be forced to choose the least of two

evils," he argued, in words Nader himself could have spoken. But in August 2024 he made

the choice he had begged Nader to make: he suspended his campaign, endorsed Donald

Trump, and asked for something no Nader-style purist had ever secured, a seat inside the

government itself.


"Go Wild on Health"


Trump's response was unlike anything any modern president had offered a consumer

advocate. "For too long, Americans have been crushed by the industrial food complex and

drug companies," Trump said in announcing Kennedy as his choice to run HHS, promising

to let him "go wild on health." Critics treated it as curiosity. It was closer to a transfer of

power.


Consider what that transfer has produced, under Trump's authority, through Kennedy's

execution:


• Phasing out petroleum-based synthetic dyes. In April 2025, HHS and the FDA

launched a national initiative to phase out eight petroleum-based synthetic dyes

from the American food supply, establishing a national standard and timeline for

transitioning to natural alternatives — as the FDA noted, ingredients food

companies already use in Europe and Canada. The initiative catalyzed concrete

commitments: General Mills to remove certified colors from its U.S. cereals and

school foods by summer 2026, Nestlé to eliminate FD&C colors from its entire U.S.

portfolio by mid-2026, Conagra's phased removal from frozen foods, and dozens of

ice-cream producers — representing over 90 percent of ice cream sold in the U.S. —

agreeing to strip artificial colors by 2028. Consumer Reports, the organization

Nader's movement helped inspire, greeted the push with a demand for more: an

enforceable ban, not just voluntary pledges. Even the argument over means is a

consumer-movement argument.


• Pressuring industry face to face. Kennedy summoned the CEOs of PepsiCo, Kraft

Heinz, General Mills, Tyson Foods, WK Kellogg, and J.M. Smucker to HHS and told

them, in effect, to remove "the worst ingredients" — or the agency would act. That is

the Nader method updated: investigate, publicize, and make the cost of doing

nothing higher than the cost of doing right.


• Facing the hardest lobby of all. When Kennedy announced the Pfizer drug-pricing

deal, he praised the CEO for "putting public health ahead of his individual interests" — while the rest of the pharmaceutical industry, as Trump noted, was expected to

fall in line. The industry's trade group called importing foreign prices "a bad deal for

American patients." When the most powerful lobby in Washington unites against

you, that is usually a sign you are standing somewhere important.

These are not the priorities of a conventional Republican administration, or a conventional

Democratic one. They are the priorities of the consumer movement, which spent decades

asking both parties to confront the food industry's influence over its own regulators and

getting neither to do it.


The Rest of the Case

The Kennedy appointment is the centerpiece, but the surrounding record reinforces the

argument:


Drug pricing. On May 12, 2025, Trump signed an executive order, "Delivering Most

Favored-Nation Prescription Drug Pricing to American Patients," demanding that Americans

no longer pay the highest drug prices in the developed world. In July, he sent letters to

seventeen leading pharmaceutical manufacturers telling them to bring U.S. prices in line

with the lowest prices paid in comparable countries. On September 30, 2025, he

announced the first agreement, with Pfizer, granting every state Medicaid program access

to most-favored-nation prices, requiring deep discounts for patients buying directly, and

launching TrumpRx, a direct-to-consumer website where Americans can buy medicine at

discounted prices without insurance. By the end of 2025, the administration had struck

MFN deals covering, it says, roughly 90 percent of the drugs Americans use.


Price transparency. Trump's first-term hospital price transparency rule, requiring hospitals

to publish the actual prices they charge — survived ferocious industry litigation and

enforcement fights, and his second administration layered on further disclosure

requirements. Like Nader's Freedom of Information Act, it rests on a simple consumer

principle: the public's right to see the numbers.

The pattern is consistent: confrontation with concentrated industries, food,

pharmaceutical, medical, on behalf of the ordinary buyer, the patient, the parent.


The Answer: Impeachment, Not Alternatives

Here is the part that should trouble anyone who considers themselves a consumer

advocate, regardless of party. The electorate has just handed Democrats control of

Congress, and the response to the most aggressive consumer-protection agenda in

decades is not a counter-proposal, it is a removal effort.Articles of impeachment against


Kennedy were filed in December 2025 by Rep. Haley

Stevens of Michigan, with Rep. Eric Swalwell as an original cosponsor. Sen. Bernie Sanders

has explicitly called for Kennedy's impeachment; Rep. James Clyburn says he is open to it;

Sen. Angela Alsobrooks demands his removal; Gov. Andy Beshear, eyeing a presidential

run, wants him fired. The Associated Press reports that when the new Congress convenes

in January, Kennedy will be among the very first oversight targets, with senior lawmakers

suggesting impeachment. Impeachment resolutions against Kennedy, like those against

other cabinet members, stalled while Republicans led the House; now that the math has

changed, the threats are becoming plans.


Notice what is absent from the debate. Where is the Democratic plan to lower drug prices

by international comparison? The alternative food-safety program? The rival price

transparency scheme? Millions of voters who backed Trump because of the Kennedy wing

of his coalition, roughly four in ten parents tell pollsters they identify with the Make America

Healthy Again agenda, are being told the answer to cheaper medicine and cleaner food

labels is the impeachment of the man pursuing it. Not a single national Democratic figure

has answered the dye phase-out with legislation, the MFN deals with a pricing bill, or the

industry pressure campaign with a competing consumer agenda.


Ralph Nader understood this dynamic better than anyone. During his 2000 run, he watched

the institutional machinery try to bargain, pressure, and shame an inconvenient advocate

out of the way rather than engage his arguments. Twenty-five years later, the playbook

looks the same, except now the target holds an office, the advocate beside him holds the

presidency, and the weapon is not an editorial page but articles of impeachment. If the

consumer agenda were truly wrong on the merits, the remedy would be a better one. The

decision to fight it with removal instead says a great deal about whose interests feel

threatened, and it is not the shopper standing in the grocery aisle.


But the Nader test was always simple: does power fear you on the public's behalf, or does it

fund you? Ralph Nader earned his place in history because General Motors tried to destroy

him and failed. Robert F. Kennedy Jr. earned his place in this story by spending forty years

suing, investigating, and confronting the industries he challenged, and then by choosing,

unlike his old mentor in 2000, to enter the building rather than protest outside it. Trump's

contribution was the one Nader never received from either party: the keys. Now the fight

over whether those keys get taken away will tell us whether consumer protection in

America has finally found a permanent home, or must once again live outside the building,

in the streets.Robert F. Kennedy Jr. suspended his independent presidential campaign and endorsed


Donald Trump in August 2024, and was nominated on November 14, 2024 to serve as

Secretary of Health and Human Services, the first career public-interest environmental

litigator to hold the post. Sources for this article include FDA and White House

announcements, the Associated Press, ABC News, CNBC, NBC News, NPR, Reuters, Time,

USA Today, The Hill, and Consumer Reports.

READ NEXT

Heading 2

Disclaimer:
 

The views and opinions expressed in the articles or Interviews published in this magazine are solely those of the respective authors and do not necessarily reflect the official policy or position of the Capitol Times magazine or Capitol Times Media , its editors, or its staff. The authors are solely responsible for the content of their articles. The magazine strives to provide a platform for diverse voices and opinions, and we value the principle of free expression. The magazine assumes no responsibility or liability for any errors or omissions in the content of the articles. In no event shall the Capitol Times magazine or Capitol Times Media be liable for any special, direct, indirect, or incidental damages. Furthermore, the inclusion of advertisements or sponsored content in Capitol Times magazine does not constitute an endorsement or guarantee of the products, services, or views promoted by the advertisers. Readers are encouraged to conduct their own research and exercise caution when making decisions based on advertisements or sponsored content featured in this publication.

Thank you for reading and engaging with our publication. Your feedback is valuable to us as we continue to provide a platform for thought-provoking content and diverse perspectives.

 

Capitol Times Media is a privately owned and independently operated media that publish Capitol Times Magazine. It is not affiliated with, endorsed by, or connected to the United States government, the U.S. Capitol, Congress, or any federal, state, or local government agency. Content published by Capitol Times Magazine includes both editorial content and sponsored or paid content.


© 2026 by Capitol Times Media LLC - Privacy Policy

bottom of page